Pages that link to "Q42183122"
Jump to navigation
Jump to search
The following pages link to Liposomes for Use in Gene Delivery (Q42183122):
Displaying 50 items.
- Solid Lipid Nanoparticles and Nanostructured Lipid Carriers: Structure, Preparation and Application (Q26778603) (← links)
- Engineering protocells: prospects for self-assembly and nanoscale production-lines (Q27010455) (← links)
- Immunogenicity and Protective Efficacy of Brugia malayi Heavy Chain Myosin as Homologous DNA, Protein and Heterologous DNA/Protein Prime Boost Vaccine in Rodent Model (Q27345320) (← links)
- Direct and sustained intracellular delivery of exogenous molecules using acoustic-transfection with high frequency ultrasound (Q27350456) (← links)
- Toxicological considerations when creating nanoparticle-based drugs and drug delivery systems (Q28395046) (← links)
- Clinical Translation of Nanomedicine. (Q30355939) (← links)
- All-in-one processing of heterogeneous human cell grafts for gene and cell therapy (Q30387995) (← links)
- Ultrasound microbubbles combined with liposome-mediated pNogo-R shRNA delivery into neural stem cells (Q30416174) (← links)
- In vitro gene delivery with ultrasound-triggered polymer microbubbles (Q30437709) (← links)
- Cell-specific multifunctional processing of heterogeneous cell systems in a single laser pulse treatment (Q30445564) (← links)
- Gene transfection efficacy assessment of human cervical cancer cells using dual-mode fluorescence microendoscopy (Q34543520) (← links)
- Increased tumor distribution and expression of histidine-rich plasmid polyplexes (Q34566500) (← links)
- A novel liposome-based nanocarrier loaded with an LPS-dsRNA cocktail for fish innate immune system stimulation (Q35034640) (← links)
- Vaccination of mice using the West Nile virus E-protein in a DNA prime-protein boost strategy stimulates cell-mediated immunity and protects mice against a lethal challenge (Q35087579) (← links)
- Cargo-delivery platforms for targeted delivery of inhibitor cargos against botulism (Q35542237) (← links)
- Intracellular trafficking of hybrid gene delivery vectors (Q35602437) (← links)
- Turning Squalene into Cationic Lipid Allows a Delivery of siRNA in Cultured Cells (Q35635285) (← links)
- Mannosylated liposomes for targeted gene delivery (Q35787498) (← links)
- Inhibition of liver fibrosis using vitamin A-coupled liposomes to deliver matrix metalloproteinase-2 siRNA in vitro (Q35919793) (← links)
- Enhancing Specific Disruption of Intracellular Protein Complexes by Hydrocarbon Stapled Peptides Using Lipid Based Delivery (Q36369753) (← links)
- Design of hybrid lipid/retroviral-like particle gene delivery vectors (Q36823864) (← links)
- Mechanistic evaluation of the transfection barriers involved in lipid-mediated gene delivery: interplay between nanostructure and composition. (Q37613191) (← links)
- Cationic liposome/DNA complexes: from structure to interactions with cellular membranes. (Q38019777) (← links)
- Heterocyclic cationic gemini surfactants: a comparative overview of their synthesis, self-assembling, physicochemical, and biological properties (Q38036135) (← links)
- Nanoparticle-Based Delivery of RNAi Therapeutics: Progress and Challenges. (Q38106032) (← links)
- Nanomedicine strategies for drug delivery to the ear. (Q38120319) (← links)
- The roles of traditional Chinese medicine in gene therapy (Q38199225) (← links)
- MicroRNA Therapeutics: the Next Magic Bullet? (Q38390631) (← links)
- Advances in nano-based inner ear delivery systems for the treatment of sensorineural hearing loss (Q38706405) (← links)
- Lipid-based nanovesicles for nanomedicine. (Q38813182) (← links)
- Alternative approaches for the treatment of airway diseases: focus on nanoparticle medicine. (Q38893756) (← links)
- Microfluidics: a transformational tool for nanomedicine development and production (Q38918919) (← links)
- Hepatic Stellate Cells in Liver Fibrosis and siRNA-Based Therapy (Q38930049) (← links)
- MicroRNA modulation combined with sunitinib as a novel therapeutic strategy for pancreatic cancer. (Q38971815) (← links)
- Microbeads mediated oral plasmid DNA delivery using polymethacrylate vectors: an effectual groundwork for colorectal cancer. (Q39005124) (← links)
- Physical properties and biological interactions of liposomes developed as a drug carrier in the field of regenerative medicine (Q39032416) (← links)
- Nanoengineered strategies for siRNA delivery: from target assessment to cancer therapeutic efficacy (Q39066848) (← links)
- Enhanced hepatic delivery of siRNA and microRNA using oleic acid based lipid nanoparticle formulations (Q39080011) (← links)
- Nanoescapology: progress toward understanding the endosomal escape of polymeric nanoparticles (Q39119319) (← links)
- Preclinical safety assessments of nano-sized constructs on cardiovascular system toxicity: A case for telemetry. (Q39121977) (← links)
- Liposome-targeted delivery for highly potent drugs (Q39171223) (← links)
- Lipid Nanovectors to Deliver RNA Oligonucleotides in Cancer (Q39196485) (← links)
- Immunogenicity of antigen-conjugated biodegradable polydiacetylene liposomes administered mucosally (Q39280954) (← links)
- Engineering liposomal nanoparticles for targeted gene therapy (Q39306702) (← links)
- Optimized polyethylenimine (PEI)-based nanoparticles for siRNA delivery, analyzed in vitro and in an ex vivo tumor tissue slice culture model (Q39662387) (← links)
- Liposomes for Targeted Delivery of Active Agents against Neurodegenerative Diseases (Alzheimer's Disease and Parkinson's Disease). (Q39803583) (← links)
- Efficient and non-toxic gene delivery by anionic lipoplexes based on polyprenyl ammonium salts and their effects on cell physiology (Q40553052) (← links)
- Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes (Q40584294) (← links)
- A pyruvate decarboxylase-mediated therapeutic strategy for mimicking yeast metabolism in cancer cells (Q41112245) (← links)
- Preparation and optimisation of anionic liposomes for delivery of small peptides and cDNA to human corneal epithelial cells (Q41154638) (← links)